Where does Adaptive Biotechnologies Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Adaptive Biotechnologies Corporation ranks #6,102 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Adaptive Biotechnologies Corporation hold?

Adaptive Biotechnologies Corporation holds 55 US utility patents granted between 2015 and 2025, spanning 12 technology areas.

What is Adaptive Biotechnologies Corporation's Innovation Score?

Adaptive Biotechnologies Corporation has an Innovation Score of 39.2 out of 100 (top 39% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Adaptive Biotechnologies Corporation's patent grant rate increasing or decreasing?

Adaptive Biotechnologies Corporation's recent grant velocity is -42% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Adaptive Biotechnologies Corporation's patents?

Adaptive Biotechnologies Corporation's patents average 18.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Adaptive Biotechnologies Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Adaptive Biotechnologies Corporation

Q: What technology areas does Adaptive Biotechnologies Corporation focus on?

Adaptive Biotechnologies Corporation's top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 51 patents, ranking #91 of 2,502 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

USPTO PatentsView assignee record - 55 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Adaptive ranks #6,102 of 49,997 tracked US assignees by granted-patent volume, with 55 patents across 12 technology areas.

#6,102
of 49,997 US assignees by volume: Top 39%
by Innovation Score (39.2/100): 18.1
avg claims per patent: -42%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6102 · US Corporation #6,102 · 55 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 55 grants
UPPER-Q #6,102/49,997
PHOTO-FINISH Allegiance
CPC-FOCUS C12Q · 12 areas
INNOV-THIN 39.2/100
CLAIMS-RICH 18.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -42% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Allegiance Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Adaptive’s 39.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.9 pts (36%) Velocity 2.1 pts (5%) Breadth 12.2 pts (31%) Claim depth 10.9 pts (28%)

Qualcomm Incorporated · highest

85
Adaptive Biotechnolo… · this assignee

39
Bwxt mPower · near

39
Impact Selector… · near

39
Ncku Research and… · near

39
Safariland · near

39
3D Lighting… · lowest

7

What this shows Adaptive's Innovation Score is 39.2/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Adaptive?

Each dot is one of Adaptive’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Adaptive’s own 18.1 claims/patent is ABOVE the 13.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Adaptive vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Adaptive's grants concentrate

Adaptive Biotechnologies Corporation is a focused PatentsView assignee: 12 CPC subclasses with 92.7% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2019 (11 grants) versus a trough of 1 in 2024. By volume, Adaptive sits between AMX LLC and Asahi Kasei E-materials Corporation.

Adaptive's three-year grant acceleration

From 2019–2021 to 2022–2024, Adaptive Biotechnologies Corporation moved from 22 to 7 grants (0.32x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

AMX

55
Ashimori Industry

55
Asia Vital Compon…

55
Autobrains

55
Allegiance

55
Amesbury Group

55
Amtrol Licensing

55
Asahi Kasei E-mat…

55
Adaptive Biotechn… ◀

55

What this shows Adaptive holds 55 patents at rank #6,107, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Adaptive

By rank, the assignees closest to #6,107 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Adaptive's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Adaptive, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Adaptive ranks #91 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Safariland, LLC 39 Impact Selector International, LLC 39 Bwxt mPower, Inc. 39 Ncku Research and Development Foundation 39

Similar claim depth

Nearest assignees by average claims per patent (18.1 here).

HRB Innovations, Inc. 18.1 avg Wowza Media Systems, LLC 18.1 avg Intellisist, Inc. 18.1 avg Inventus Holdings, LLC 18.1 avg

Adaptive's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Adaptive Biotechnologies Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	5.5%
2016	10	18.2%
2017	2	3.6%
2018	5	9.1%
2019	11	20.0%
2020	3	5.5%
2021	8	14.5%
2022	4	7.3%
2023	2	3.6%
2024	1	1.8%
2025partial year	6	10.9%

Which technologies does Adaptive Biotechnologies Corporation patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 51

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 15

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 12

Y02A - Technologies FOR Adaptation TO Climate Change 11

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

C07K - Peptides 4

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

G16Z - Information AND Communication Technology [ICT] Specially Adapted FOR Specific Application Fields, NOT Otherwise Provided FOR 3

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 3

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Adaptive Biotechnologies Corporation's patent record in context - here's where to go next.

Adaptive Biotechnologies Corporation's lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 92.7% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #6,102 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Adaptive Biotechnologies Corporation against AMX LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.